Tibbiyah’s unit awarded SAR 493.4M contract by nupco

Arabian International Healthcare Holding Co. (Tibbiyah) announced that Genalive Medical Co., a 50:50 joint venture with BGI, won a tender for 933,782 laboratory tests from National Unified Procurement Co. (nupco), at a total value of SAR 493.4 million.

In a statement to Tadawul, Tibbiyah said these tests will serve nearly one million patients at 83 governmental, military, and university hospitals across the Kingdom.

This initiative ensures access to accurate diagnostics for a wide range of severe and chronic diseases, supporting various medical specialties, including oncology, genetics, pediatrics, gynecology, and more, ultimately enhancing patient care Kingdom-wide.

Genalive’s financial statements are not consolidated into Tibbiyah. However, the financial impact will appear in Tibbiyah’s profit share from equity investees.